In vivo growth inhibitory effect of iterative wild-type p53 gene transfer in human head and neck carcinoma xenografts using glucosylated polyethylenimine nonviral vector
Open Access
- 24 July 2002
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 9 (8), 708-714
- https://doi.org/10.1038/sj.cgt.7700485
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Receptor-mediated gene delivery to human peripheral blood mononuclear cells using anti-CD3 antibody coupled to polyethylenimineGene Therapy, 2001
- Current role of gene therapy in head and neck cancerEuropean Journal of Surgical Oncology, 2000
- Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type p53 (Ad-p53)Cancer Gene Therapy, 2000
- Polyethylenimine-based intravenous delivery of transgenes to mouse lungGene Therapy, 1998
- Gene transfer with lipospermines and polyethyleniminesAdvanced Drug Delivery Reviews, 1998
- Nonviral Gene Delivery to the Rat Kidney with PolyethylenimineHuman Gene Therapy, 1997
- Gene therapy for lung cancer: Enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transferThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Molecular staging of head and neck squamous carcinomaCancer and Metastasis Reviews, 1996
- A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.Proceedings of the National Academy of Sciences, 1995
- Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake.Proceedings of the National Academy of Sciences, 1994